ANRISK® is an AI-powered risk assessment solution that predicts the likelihood of brain aneurysm development using routine health check-up data alone. Designed as a pre-screening tool prior to brain vascular imaging such as MRA or CTA, ANRISK® enables safe, fast, and cost-effective identification of...
Manufactured by
South Korea
TALOS Corp. is a medical AI company dedicated to predicting and preventing severe diseases before they occur. Founded by neurosurgeons with extensive clinical experience, TALOS aims to shift healthcare from a treatment-centered model to a prevention-centered paradigm through data-driven medical intelligence. Its flagship solution, ANRISK®, is an AI-based risk assessment service that predicts the likelihood of brain aneurysm development using only routine health check-up data. Developed using approximately 8.8 million person-years of national healthcare data, ANRISK® has received regulatory approvals in South Korea, Japan, Vietnam, and Taiwan. The solution is currently adopted by hospitals, public healthcare institutions, health screening centers, and corporate health programs across multiple countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
DeepCardio Co. LTD.
South Korea · 2 relevant products
KARDI AI Technologies s.r.o
Czech Republic · 3 relevant products
AXIS Healthcare Trading FZE
United Arab Emirates · 1 relevant product
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 68 closest product alternatives
DeepCardio Co. LTD. · South Korea
AI-based software solution that analyzes 10-second normal sinus rhythm ECG data to predict atrial fibrillation risk and identify patients at potential risk for arrhythmia development. The system provides quantified risk assessment to support clinical decision-making for early detection and preventive management.
KARDI AI Technologies s.r.o · Czech Republic
AI-based computational tool for assessing patient risk of adverse cardiac events. Integrates multiple clinical, imaging, and laboratory parameters to generate personalized risk scores. Supports evidence-based decision-making for patient management and treatment planning.
AXIS Healthcare Trading FZE · United Arab Emirates
AI-powered cardiovascular risk assessment system that analyzes patient data to identify and stratify cardiac risk factors. Integrates clinical parameters and diagnostic indicators to support evidence-based clinical decision-making and preventive cardiology interventions.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products